Frontiers in Cancer Control and Society

Open Access Policy: Articles are published under a gold open-access model and are freely available to readers.

License: Creative Commons Attribution (CC BY), according to the publisher's open-access statement.

Peer Review Policy: Single-anonymized peer review. Authors' identities are visible to reviewers, while reviewer identities are not disclosed to authors.

Publication Ethics: The journal is a member of the Committee on Publication Ethics (COPE).

Originality and Plagiarism: Submitted manuscripts are checked for compliance with the publisher's originality and publication ethics requirements.

Research Integrity: Authors must report methods, findings, limitations, and analyses accurately and transparently.

Data Availability: Authors should provide data availability statements and share supporting research data when appropriate, subject to ethical, legal, and privacy restrictions.

Human Participants: Research involving people or personal health data must comply with applicable ethical standards and institutional requirements.

Conflicts of Interest: Authors must disclose relevant competing interests.

Corrections and Retractions: Post-publication corrections and other editorial actions follow the publisher's applicable policies.

Scope Policy: Manuscripts must have a clear connection to cancer prevention or control in society. Basic cancer science or clinical treatment research without this connection is not suitable.

Editorial Independence: Editorial decisions follow the journal's peer-review process. Payment of publication charges does not guarantee acceptance.

Authors must submit manuscripts to the specialty section most appropriate to their research question and demonstrate a clear contribution to cancer prevention or control at the population or societal level.

Manuscripts should present scientifically rigorous research, appropriate methods, and findings relevant to public health, cancer epidemiology, screening, survival, social determinants, or cancer support.

Authors must:

• Follow the journal's current manuscript preparation and submission requirements.
• Select an article type accepted by the relevant specialty section.
• Include a title, abstract, keywords, references, figures, and tables where applicable.
• Describe study design, participant selection, data sources, statistical analyses, and limitations in sufficient detail.
• Use appropriate reporting guidelines, such as STROBE for observational studies or CONSORT for randomized trials, when applicable.
• Explain the implications of the findings for cancer control, public health, policy, or population outcomes.
• Disclose funding sources, author contributions, and competing interests.
• Obtain required ethics approvals and informed consent where applicable.
• Protect participant confidentiality and handle sensitive health data appropriately.
• Provide data availability statements and share supporting materials when appropriate and legally permitted.
• Respond to editorial and reviewer comments during peer review.

Research focused exclusively on basic cancer science or clinical diagnosis and treatment, without a clear link to cancer control in society, is outside the journal's stated scope.